Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Origin Agritech is a leading Chinese agricultural biotechnology company specializing in the development, production, and distribution of hybrid crop seeds with advanced genetic traits. Its phytase corn was the first transgenic corn to receive a Bio-Safety Certificate from China’s Ministry of Agriculture. The company's pipeline includes GMO seeds with glyphosate tolerance and pest resistance traits. It is positioned to benefit from recent positive regulatory changes regarding GMO crop commercialization in China[2][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Origin Agritech.